Chromatography
Application of exact mass ms in bioanalysis discovery quantitation with uplc and xevo qtof ms
Mar 01 2010
Author: Robert S. Plumb and Marian Twohig on behalf of Waters Corporation
The quantification of candidate pharmaceuticals and/or their metabolites in biological fluids plays a key role in drug discovery. The information generated is used to determine key pharmacokinetics parameters such as clearance, half-life, Tmax, and bioavailability. During discovery ADME studies the metabolic fate of the molecule is determined as well as its pharmacokinetics. Currently this involves using two analytical instruments: one to provide the quantitative information and one for the qualitative analysis. Quantitative information is normally derived from a tandem quadrupole instrument due to sensitivity; qualitative data is gathered either from an ion trap or quadrupole time-of-flight MS (QTof) instrument. This need for multiple instruments and analytical runs results in reduced productivity and increased instrument capital costs. QTof technology is well-recognized as the platform of choice for exact mass MS/MS structural elucidation.1-3 However, its use in quantitative DMPK studies has yet to be fully exploited. In this application note, we present the use of a high-sensitivity QTof mass spectrometer coupled with UltraPerformance LC® (UPLC®) separation technology for the quantitative analysis of a model candidate pharmaceutical at the levels of sensitivity required for drug discovery.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria
May 22 2024 Basel, Switzerland